“…In addition, the RF (reversal fold) values of all three P-gp inhibitors (verapamil 24.3, cyclosporin A 72.6, tariquidar 283.2) were consistent with previous reports. − Furthermore, compounds c1–c31 showed acceptable MDR reversal activity with RF ranging from 10.0 to 204.4, wherein the RF values of compounds c3, c10, c12, c13, c14, c16, c17, c23 , and c30 were 204.4, 99.1, 88.3, 112.7, 108.7, 86.4, 137.6, 76.3, and 100.4, respectively. The results indicated that the RF values of these compounds exceeded those of the first-generation P-gp inhibitors verapamil, cyclosporin, and reported phenylfuran, phenylthiophene, phenylpyridine, and phenylpyrimidine derivatives, − which were consistent with the results predicted by the abovementioned molecular simulations.…”